Erytech is a startup based in Germany, most recent round Series-c-plus, 3 tracked investors.
Erytech is a company founded in 2005 headquartered in Germany. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
A clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.